UNOV vs SNY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SNY Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) driven by superior Valuation, Growth & Margin, Options & Structure while UNOV counters with relative strength in Momentum & Technical. Fundamentally, UNOV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SNY at 8.9x Forward P/E and 22.3% operating margin (+15.7% YoY). In options structure, UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNY sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UNOV | SNY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $116.1B | Larger Scale | SNY |
| Trailing P/E Ratio Valuation | N/M | 24.1x | Lower Multiple | SNY |
| Forward P/E Ratio Valuation | N/M | 8.9x | Lower Multiple | SNY |
| Revenue Growth (YoY) Growth | N/A | +15.7% | Higher Growth | SNY |
| Operating Margin (TTM) Profitability | N/A | 22.3% | Higher Margin | SNY |
| Net Profit Margin Profitability | N/A | 8.2% | Higher Margin | SNY |
| Return on Equity (ROE) Capital Efficiency | N/A | 5.7% | Higher ROE | SNY |
| 52-Week Range Position Momentum | 84% ($37โ$42) | 68% ($39โ$53) | Stronger Trend | UNOV |
| Beta / 30D Volatility Risk Regime | 0.46ฮฒ ยท 11% Vol | 0.21ฮฒ ยท 27% Vol | Lower Realized Risk | UNOV |
| Unified Institutional Score Composite Signal | 58.7 / 100 (HOLD) | 31.7 / 100 (SELL) | Higher Composite | UNOV |